Jerini expands collaboration with Baxter to develop non-intraveneous hemophilia therapy
Jerini AG announced the expansion of their current research collaboration with Baxter AG for the development of a non-intravenous therapy for the treatment of hemophilia. The companies have initiated two additional programs aimed at novel targets, potentially offering new therapeutic develo ... more
